Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Picolinic acid is a naturally occurring pyridine carboxylate and a catabolite of the amino acid tryptophan, produced in the body via the kynurenine pathway[1][2][3][6]. It functions as a bidentate chelating agent for divalent and trivalent metal ions such as zinc, chromium, manganese, copper, iron, and molybdenum[3][4][6]. Picolinic acid plays an important role in zinc transport and absorption in the human body[1][2][3]. As an endogenous metabolite, it has been implicated in neuroprotective, immunological, anti-proliferative effects and may modulate immune responses by enhancing interferon-gamma-induced nitric oxide synthase expression in macrophages[7][8]. Therapeutically investigated as an anti-infective and immunomodulator with antiviral activity (in vitro/in vivo), it can disrupt viral replication by binding to zinc finger proteins involved in viral packaging. Potential indications include acne vulgaris, herpes labialis infections (cold sores), venereal disease, and possibly other inflammatory or infectious conditions[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Picolinic acid.